Insiders / Balcom Alexandra / Activity

Activity — Balcom Alexandra

16 moves.

BiggestBiggest buysBiggest sellsHighest impact
InsidersInstitutions
DateActionCompanyValueShares ΔPosition afterImpact
Mar 25, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$1.37M-14K
-13.81%
85,533
0.11% of shares
medium
Mar 24, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$735.5K-8K
-7.10%
100,393
0.13% of shares
medium
Mar 24, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$247.0K-3K
-2.35%
108,064
0.14% of shares
medium
Jan 5, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$189.0K-2K
-2.21%
85,231
0.11% of shares
medium
Jan 6, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$159.1K-2K
-1.96%
81,958
0.10% of shares
medium
Jan 6, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$127.8K-1K
-1.56%
83,593
0.11% of shares
medium
Mar 24, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$111.9K-1K
-1.16%
99,233
0.13% of shares
medium
Jan 5, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$108.4K-1K
-1.27%
87,160
0.11% of shares
medium
Jan 5, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$83.7K-871
-0.98%
88,279
0.11% of shares
low
Jan 5, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$31.2K-317
-0.37%
84,914
0.11% of shares
low
Jan 6, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$22.1K-225
-0.27%
81,733
0.10% of shares
low
Mar 24, 2026ExerciseNUVL
Nuvalent, Inc.
Class A Common Stock
$12.3K+11K
+11.52%
110,663
0.14% of shares
low
Jan 7, 2026GrantNUVL
Nuvalent, Inc.
Class A Common Stock
$0+18K
+21.41%
99,233
0.13% of shares
low
Jun 2, 2026GrantCBIO
Crescent Biopharma, Inc.
Stock Option (Right to Buy)
+11K
11,050
0.03% of shares
low
Mar 24, 2026ExerciseNUVL
Nuvalent, Inc.
Stock Option (Right to Buy)
-11K
-7.07%
150,226
0.19% of shares
low
Jan 7, 2026GrantNUVL
Nuvalent, Inc.
Stock Option (Right to Buy)
+18K
17,500
0.02% of shares
low
← PrevPage 1 of 1Next →